Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This phase II single arm, open-label study investigate the safety of a second cycle of
catumaxomab in patients with malignant ascites due to carcinoma, requiring their first
therapeutic puncture after treatment in the CASIMAS study.